Insider Shareholders with Direct Ownership of Lexeo Therapeutics, Inc. (LXEO)
This section provides a comprehensive overview of the insiders with direct ownership of Lexeo Therapeutics, Inc. (LXEO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lexeo Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Omega Fund Vi, L.P.
> 10% Shareholder |
2,157,623 | 0 | 2,157,623 | 1 |
Nov 07, 2023
Added 17.4%
|
|
Invest A/S Lundbeckfond
> 10% Shareholder |
1,835,959 | 0 | 1,835,959 | 1 |
Nov 07, 2023
Added 11.02%
|
|
Richard Nolan Townsend
Chief Executive Officer |
73,750 | 80,000 | 120,695 | 14 |
Oct 10, 2024
Reduced 3.98%
|
|
Jose Manuel Otero
Chief Technical Officer |
31,250 | 0 | 31,250 | 1 |
Jun 12, 2024
Added 50.0%
|
|
Eric Adler
Chief Medical Officer |
26,875 | 0 | 26,875 | 1 |
Feb 02, 2024
Added 50.0%
|
|
Jenny Robertson
Chief Legal and Admin Officer |
23,750 | 0 | 23,750 | 1 |
Jan 05, 2024
Added 50.0%
|
|
Paul Mc Cormac
Chief Technical Officer |
3,191 | 0 | 17,349 | 1 |
Nov 07, 2023
Added 15.54%
|